<img height="1" width="1" style="display:none;" alt="" src="https://dc.ads.linkedin.com/collect/?pid=412980&amp;fmt=gif">
LSX-Blog.png

Something Powerful

Tell The Reader More

The headline and subheader tells us what you're offering, and the form header closes the deal. Over here you can explain why your offer is so great it's worth filling out a form for.

Remember:

  • Bullets are great
  • For spelling out benefits and
  • Turning visitors into leads.

Life science insights: Looking back at 2018

As we come to the end of 2018, we look back at some of the interviews, case...

Read More

Vital signs in UK life sciences

In 2017, Professor Sir John Bell published the well-received Life Sciences ...

Read More

A Right Pain in the Peripheries? The Supreme Court...

Summary

Read More

Medius Deal Watch: September-October 2018

There was much speculation last year that the US tax cuts that favoured the...

Read More

AI update: medical software and pre-emption

In light of the rapidly expanding field of medical software technology, and...

Read More

Artificial intelligence and machine learning in he...

Artificial intelligence (AI), particularly machine learning (ML), is alread...

Read More

Addressing emerging themes in life science IP

Marks & Clerk’s intellectual property (IP) summit in Cambridge on 16 Octobe...

Read More

Driving developments to defeat ageing: Q&A with Au...

In February 2019, key stakeholders in the growing longevity industry will c...

Read More

Rethinking the growth capital challenge in UK life...

Investors, entrepreneurs and deal makers in the UK life sciences industry m...

Read More

M&A deals and the pharmaceutical sector: Are your ...

2018 has so far been a productive year for M&A deals in the pharmaceutical ...

Read More

Dyadic International: Working to change the game i...

Key learnings:

Read More

What life sciences companies need to know about pr...

Pre-approval access is evolving at a rapid pace. Mark Corbett (pictured), E...

Read More

Add Your Response